Sign in
4

Changes in Ownership

Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-19-055930

Chief Commercial Officer bought 1,000 shares at $4.38 ($4,380)

From the SEC's structured data for this filing

Trades in this filing

Millian Craig Stuart · Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-11-11 Purchase : show line 1 in the form +1,000 $4.38 $4,380 10,000 D
Open-market purchases · 1,000 sh · avg $4.38 · $4,380
Loading xslF345X03/doc4.xml…